益心舒胶囊治疗冠心病心绞痛50例临床分析

Clinical analysis of Yi Xin Shu capsule in the treatment of 50 cases of angina pectoris of coronary heart disease

目的:探讨益心舒胶囊治疗冠心病心绞痛的临床疗效。方法:2013年9月-2014年9月收治冠心病心绞痛患者100例,随机分成对照组和观察组,各50例。对照组给予β受体阻滞剂、硝酸酯类药物和(或)钙拮抗剂、阿司匹林治疗;观察组在对照组的基础上加用益心舒胶囊3粒/次,3次/d,两组均连续治疗8周。结果:经过治疗观察组胸痛消失48例,胸闷消失48例,心悸消失49例,气短消失49例;对照组胸痛消失39例,胸闷消失37例,心悸消失35例,气短消失36例,两组比较差异有统计学意义(P<0.05)。观察组总有效率94.0%,对照组总有效率84.0%,两组比较差异有统计学意义(P<0.05)。结论:益心舒胶囊治疗冠心病心绞痛疗效显著,值得推广。

Objective:To investigate the clinical efficacy of Yi Xin Shu capsule in the treatment of angina pectoris of coronary heart disease.Methods: 100 patients with angina pectoris of coronary heart disease were selected from September 2013 to September 2014.They were randomly divided into the control group and the observation group with 50 cases in each.The control group patients were given beta blockers,nitrates and(or) calcium antagonist antagonist,aspirin therapy.The observation group were given Yi Xin Shu capsule 3 grain/time based on the control group,3 times/d.Two groups were treated continuously for 8 weeks.Results:After the treatment,the observation group chest pain disappeared in 48 cases;chest tightness disappeared in 48 cases;palpitations disappeared in 49 cases;shortness of breath and disappeared in 49 cases.The control group of chest pain disappeared in 39 cases;chest tightness disappeared in 37 cases;heart palpitations and disappeared in 35 cases;shortness of breath disappeared in 36 cases;the two groups had statistical significance(P<0.05).The observation group total effectiveness was 94%;the comparison group total effectiveness was 84%;the difference of two groups had statistically significant(P<0.05).Conclusion:Yi Xin Shu capsule in the treatment of angina pectoris of coronary heart disease has significant curative effect,so it is worth promoting.